PER3 Primary Antibody

Item Information
Catalog #Size/ConcentrationPrice
Specification
AliasesGIG13
ProductOrderP
Clone#5D5B8
Entrez GenelD8863
FormulationPurified antibody in PBS with 0.05% sodium azide.
HostMouse
IsotypeIgG1
ImmunogenPurified recombinant fragment of human PER3 (AA: 723-954) expressed in E. Coli.
MW132kDa
Shipping InformationThis product will ship in a box containing blue ice at a temperature of 4°C. Learn More
Species ReactivityHuman
Application
ELISA1/10000
WB (Western Blot)1/500 - 1/2000
Sequence
723-954
Catalog#: 30684
Inquire
Contact us to order
Images
Western Blot
Figure 1: Western blot analysis using PER3 mAb against human PER3 (AA: 723-954) recombinant protein. (Expected MW is 50.7 kDa)
Figure 1: Western blot analysis using PER3 mAb against human PER3 (AA: 723-954) recombinant protein. (Expected MW is 50.7 kDa)
Western Blot
Figure 2: Western blot analysis using PER3 mAb against HEK293 (1) and PER3 (AA: 723-954)-hIgGFc transfected HEK293 (2) cell lysate.
Figure 2: Western blot analysis using PER3 mAb against HEK293 (1) and PER3 (AA: 723-954)-hIgGFc transfected HEK293 (2) cell lysate.
Elisa
Black line: Control Antigen (100 ng); Purple line: Antigen(10ng); Blue line: Antigen (50 ng); Red line: Antigen (100 ng);
Black line: Control Antigen (100 ng); Purple line: Antigen(10ng); Blue line: Antigen (50 ng); Red line: Antigen (100 ng);
Product Overview
Description

This gene is a member of the Period family of genes and is expressed in a circadian pattern in the suprachiasmatic nucleus, the primary circadian pacemaker in the mammalian brain. Genes in this family encode components of the circadian rhythms of locomotor activity, metabolism, and behavior. Circadian expression in the suprachiasmatic nucleus continues in constant darkness, and a shift in the light/dark cycle evokes a proportional shift of gene expression in the suprachiasmatic nucleus. The specific function of this gene is not yet known.

References (references)
References (references)1. Liver Int. 2012 Oct;32(9):1451-9.
2. Ann Surg Oncol. 2012 Sep;19(9):3081-8.